The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Estrogen-Receptor Biology: Continuing Progress and Therapeutic Implications
Abstract
Endocrine therapies, first used more than 100 years ago, are the most effective treatments for breast cancers expressing the estrogen receptor (ER). All endocrine therapies are designed to block ER function in some way, thereby making them the first targeted therapies used for cancer. Selective ER modulators (SERMs) such as tamoxifen bindERandpartially block its activity.Ovarian ablation, luteinizing hormone–releasing hormone agonists, and aromatase inhibitors reduce the level of estrogen and inhibit ligand-induced activation of ER. Steroidal antiestrogens such as fulvestrant bind ER, more completely block its function, and induce receptor degradation.While all of these therapies are effective in certain patients, de novo and acquired resistance remain major problems. New information on the biology of ER provides insight into the mechanisms of treatment resistance and new strategies to overcome it, thereby potentially making these therapies even more effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
Shou, J., Massarweh, S., Osborne, C. K., Wakeling, A. E., Ali, S., Weiss, H., & Schiff, R. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh166 · Cited by 1,153
Self-citationMolecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146
Ellis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Nuclear receptor coactivators and corepressors
Horwitz, K. B. (1996) · Molecular Endocrinology · doi:10.1210/me.10.10.1167 · Cited by 942
Estrogen receptor pathways to AP-1
Kushner, P. J., Agard, D. A., Greene, G. L., Scanlan, T. S., Shiau, A. K., Uht, R. M., & Webb, P. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00108-4 · Cited by 870
Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A. W., Wong, J., Allred, D. C., Clark, G. M., & Schiff, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.353 · Cited by 786
Self-citationSpecific binding sites for oestrogen at the outer surfaces of isolated endometrial cells
PIETRAS, R. J., & SZEGO, C. M. (1977) · Nature · doi:10.1038/265069a0 · Cited by 691
Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.657 · Cited by 662
Nongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561
Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway
Kahlert, S., Nuedling, S., van Eickels, M., Vetter, H., Meyer, R., & Grohé, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910345199 · Cited by 474
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
Castoria, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6050 · Cited by 468
Li, L., Haynes, M. P., & Bender, J. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831079100 · Cited by 465
Ali, S., Metzger, D., Bornert, J. M., & Chambon, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05756.x · Cited by 448
AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor
Font de Mora, J., & Brown, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5041-5047.2000 · Cited by 432
Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions
Safe, S. (2001) · Vitamins & Hormones · doi:10.1016/s0083-6729(01)62006-5 · Cited by 418
Song, R. X.-D., McPherson, R. A., Adam, L., Bao, Y., Shupnik, M., Kumar, R., & Santen, R. J. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.1.0748 · Cited by 407
Filardo, E. J. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00190-x · Cited by 373
Selective Estrogen Receptor Modulators: Structure, Function, and Clinical Use
Osborne, C. K., Zhao, H. (., & Fuqua, S. A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3172 · Cited by 367
Self-citationKurokawa, H., Lenferink, A. E. G., Simpson, J. F., Pisacane, P. I., Sliwkowski, M. X., Forbes, J. T., & Arteaga, C. L. (2000) · PubMed · Cited by 363
CORRELATIONS BETWEEN THE CHEMICAL STRUCTURE AND THE PHARMACOLOGICAL ACTIONS OF THE STEROIDS1
SELYE, H. (1942) · Endocrinology · doi:10.1210/endo-30-3-437 · Cited by 348
Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M., Truss, M., Beato, M., Sica, V., Bresciani, F., & Weisz, A. (1996) · PubMed · Cited by 343
Bidirectional Signaling between the Estrogen Receptor and the Epidermal Growth Factor Receptor
Levin, E. R. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0368 · Cited by 329
Cellular functions of plasma membrane estrogen receptors
Levin, E. R. (2002) · Steroids · doi:10.1016/s0039-128x(01)00179-9 · Cited by 328
Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
Masamura, S. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.10.2918 · Cited by 307
Cloning of the human oestrogen receptor cDNA
Green, S., Walter, P., Greene, G., Krust, A., Goffin, C., Jensen, E., Scrace, G., Waterfield, M., & Chambon, P. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90035-x · Cited by 302
Invited Review: Cell localization, physiology, and nongenomic actions of estrogen receptors
Levin, E. R. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.4.1860 · Cited by 293
McInerney, E. M., Weis, K. E., Sun, J., Mosselman, S., & Katzenellenbogen, B. S. (1998) · Endocrinology · doi:10.1210/endo.139.11.6298 · Cited by 269
Dong, L., Wang, W., Wang, F., Stoner, M., Reed, J. C., Harigai, M., Samudio, I., Kladde, M. P., Vyhlidal, C., & Safe, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32099 · Cited by 259
Ray, P., Ghosh, S. K., Zhang, D.-H., & Ray, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00487-0 · Cited by 256
Montano, M. M. (1995) · Molecular Endocrinology · doi:10.1210/me.9.7.814 · Cited by 246
A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm
Kumar, R., Wang, R.-A., Mazumdar, A., Talukder, A. H., Mandal, M., Yang, Z., Bagheri-Yarmand, R., Sahin, A., Hortobagyi, G., Adam, L., et al. (2002) · Nature · doi:10.1038/nature00889 · Cited by 242
Oxidative Stress and AP-1 Activity in Tamoxifen-Resistant Breast Tumors In Vivo
Schiff, R. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1926 · Cited by 211
Self-citationMolecular Cloning and Characterization of PELP1, a Novel Human Coregulator of Estrogen Receptor α
Vadlamudi, R. K., Wang, R.-A., Mazumdar, A., Sahin, A., Kumar, R., Kim, Y.-S., & Shin, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103783200 · Cited by 198
Low Levels of Estrogen Receptor β Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer
Hopp, T. A., Weiss, H. L., Parra, I. S., Cui, Y., Osborne, C. K., & Fuqua, S. A. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1114 · Cited by 197
Self-citationBouras, T., Southey, M. C., & Venter, D. J. (2001) · PubMed · Cited by 196
Estrogen receptor: current understanding of its activation and modulation.
Osborne, C. K., Schiff, R., Fuqua, S. A. W., & Shou, J. (2001) · PubMed · Cited by 194
Self-citationHong, S.-H., & Privalsky, M. L. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6612-6625.2000 · Cited by 186
Estrogen receptor beta expression in invasive breast cancer
Mann, S., Laucirica, R., Carlson, N., Younes, P. S., Ali, N., Younes, A., Li, Y., & Younes, M. (2001) · Human Pathology · doi:10.1053/hupa.2001.21506 · Cited by 183
Johnston, S. R. D., Lü, B., Scott, G. K., Kushner, P. J., Smith, I. E., Dowsett, M., & Benz, C. C. (1999) · PubMed · Cited by 172
Figtree, G. A., McDonald, D., Watkins, H. C., & Channon, K. M. (2003) · Circulation · doi:10.1161/01.cir.0000043805.11780.f5 · Cited by 168
Distinct steady–state nuclear receptor coregulator complexes exist in vivo
McKenna, N. J., Nawaz, Z., Tsai, S. Y., Tsai, M.-J., & O’Malley, B. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11697 · Cited by 167
Estrogen receptor corepressors -- a role in human breast cancer?
Dobrzycka, K. M., Townson, S. M., Jiang, S., & Oesterreich, S. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100517 · Cited by 160
Nonnuclear Actions of Estrogen
Ho, K. J., & Liao, J. K. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000041200.85946.4a · Cited by 144
List, H.-J., Lauritsen, K. J., Reiter, R., Powers, C., Wellstein, A., & Riegel, A. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102397200 · Cited by 134
Liu, Y., Ludes-Meyers, J. H., Zhang, Y., Munoz‐Medellin, D., Kim, H.-T., Lü, C., Ge, G., Schiff, R., Hilsenbeck, S. G., Osborne, C. K., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205883 · Cited by 128
Self-citationSong, R. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.116 · Cited by 125
Balasenthil, S., & Vadlamudi, R. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212822200 · Cited by 92
The role of HER-2 expression in predicting response to therapy in breast cancer.
MASS, R. D. (2000) · PubMed · Cited by 92
Upstream Stimulatory Factors Mediate Estrogen Receptor Activation of the Cathepsin D Promoter
Xing, W., & Archer, T. (1998) · Molecular Endocrinology · doi:10.1210/me.12.9.1310 · Cited by 72
Geum, D., Sun, W., Paik, S. K., Lee, C. C., & Kim, K. (1997) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199704)46:4<450::aid-mrd2>3.0.co;2-n · Cited by 68
Nicholson, R. I., Hutcheson, I. R., Harper, M. E., et al. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04101.x · Cited by 65
Cited by
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Deconstructing the molecular portraits of breast cancer
Prat, A., & Perou, C. M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2010.11.003 · Cited by 1,343
Virtual and biomolecular screening converge on a selective agonist for GPR30
Bologa, C. G., Revankar, C. M., Young, S. M., Edwards, B. S., Arterburn, J. B., Kiselyov, A. S., Parker, M. A., Tkachenko, S. E., Savchuck, N. P., Sklar, L. A., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio775 · Cited by 818
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Arpino, G., Wiechmann, L., Osborne, C. K., & Schiff, R. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0045 · Cited by 549
Self-citation
Metadata
- Authors
- Osborne, C. K., & Schiff, R.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-03-10
- Volume
- 23
- Issue
- 8
- Pages
- 1616-1622
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2135278339
- Cited by
- 351
- References
- 56
- FWCI
- 17.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.